Combined TNF Inhibitor and Growth Factor Serum
Bulk mixed preparation of tumor necrosis factor (TNF) inhibitors like infliximab with growth factors (GF) for autoimmune disease modulation. HTS 3002.14.00 applies to such mixed immunological products (TNF, GF) obtained biotechnologically, excluding retail forms.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If derived from blood fractions rather than biotech
Antisera/other blood fractions classify under 3002.10, distinct from biotech immunological products.
If put up in retail doses as medicaments
Mixed products in retail forms move to Chapter 30 headings 3003/3004.
If for industrial enzyme use, not therapeutic
Peptones/enzymes not for immunological therapy classify under 3504 for commercial applications.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Include biotech origin certificates showing modification processes for TNF/GF regulation
• Avoid measured dose packaging; bulk drums qualify for 3002.14 over retail headings
Related Products under HTS 3002.14.00
Colony Stimulating Factor and Interferon Mix
Bulk blend of CSF and IFN for enhancing immune response in chemotherapy patients. Fits 3002.14.00 as mixed immunological products (CSF, IFN) not put up for retail.
Mixed Interleukin and TNF Preparation
Combined IL and TNF modulators for rheumatoid arthritis therapy in bulk form. 3002.14.00 for mixed interleukins/TNF immunologicals.
Biotech Antibody and Chemokine Solution
Mixed MAB and chemokine solution for inflammation control. HTS 3002.14.00 applies.
Growth Factor and MAB Blend
Bulk GF-MAB mix for wound healing immunology.
Hematopoietin Antibody Cocktail
Mixed hematopoietin and antibody for blood disorders.
Mixed Monoclonal Antibody Cocktail for Cancer Therapy
A blended preparation of multiple monoclonal antibodies (MABs) such as trastuzumab and pertuzumab for targeted cancer immunotherapy. Classified under HTS 3002.14.00 as mixed immunological products not in measured doses or retail packaging, involving peptides and proteins regulating immunological processes.